| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/28/2006 | US20060218665 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
| 09/28/2006 | US20060217534 Bis (amino acid) molecular scaffolds |
| 09/28/2006 | US20060217531 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 09/28/2006 | US20060217530 Active against C5a receptors on polymorphonuclear leukocytes and macrophages; peptidomimetics; for treatment of inflammation |
| 09/28/2006 | US20060217529 Method for Producing Insulin From a Natural Source and Insulin Produced by Said Method |
| 09/28/2006 | US20060217429 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
| 09/28/2006 | US20060217339 Breast cancer, prostate cancer, brain cancer, head and neck cancer, myeloma, melanoma, leukemia and lymphoma; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools. |
| 09/28/2006 | US20060217337 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060217336 Synthesizing a double stranded nucleic acid molecule used for treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 09/28/2006 | US20060217335 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060217334 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060217328 Derivatized with a glycerol linker, 2'-deoxy-7-deazaguanosine and arabinoguanosine; immunomer is self-complementary; anticarcinogenic, antiinflammatory, antiallergen, antihistamine, and bronchodilator agents; asthma, skin disorders |
| 09/28/2006 | US20060217326 Group of nucleic acid fragments for prevention of hiv infection or aids and the usage thereof |
| 09/28/2006 | US20060217325 Treatment of dry eye restoring 15-lipoxygenase activity to ocular surface cells |
| 09/28/2006 | US20060217321 Compositions to improve tic disorders |
| 09/28/2006 | US20060217320 Soft gel formulations for saquinavir |
| 09/28/2006 | US20060217319 Method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 09/28/2006 | US20060217318 Ace inhibitory peptides from plant materials |
| 09/28/2006 | US20060217317 Proteases of human kallikrein 2 (hK2); tissue imaging |
| 09/28/2006 | US20060217316 Method for the treatment of prostate cancer |
| 09/28/2006 | US20060217315 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
| 09/28/2006 | US20060217314 Feline hepatocyte growth factor |
| 09/28/2006 | US20060217313 5-CNAC as oral delivery agent for parathyroid hormone fragments |
| 09/28/2006 | US20060217312 Charged lipoprotein complexes and their uses |
| 09/28/2006 | US20060217311 VEGF antagonist formulations |
| 09/28/2006 | US20060217310 Fibroblast growth factor 1 (FGF-1) used for skin care |
| 09/28/2006 | US20060217309 Novel cyclosporine analog formulations |
| 09/28/2006 | US20060217308 Compositions for the treatment of tumor pathologies, comprising internalin B (ln1B) of Listeria monocytogene protein or a fragment thereof |
| 09/28/2006 | US20060217307 Methods for regulating inflammatory mediators and peptides useful therein |
| 09/28/2006 | US20060217306 Systemic treatment of infections with defensins |
| 09/28/2006 | US20060217305 Induction of tumor cell senescence by retinoid receptor agonists and antagonists |
| 09/28/2006 | US20060217304 Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders |
| 09/28/2006 | US20060217303 Compounds and Methods for Treating Seizure Disorders |
| 09/28/2006 | US20060217302 Paralytic peptide for use in neuromuscular therapy |
| 09/28/2006 | US20060217301 Inducing proliferation of lymphoid lineage progenitor cells or progeny bywith Bv8 or a mixture of Bv8 and endothelial growth factor, EG-VEGF; increasing the population of T lymphocytes and CD4 antigen, white blood cells followingimmunosuppressant therapy; HIV |
| 09/28/2006 | US20060217300 Analogues of glp-1 |
| 09/28/2006 | US20060217299 Degradation inhibitor for hepatitis b virus x interacting protein |
| 09/28/2006 | US20060217298 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 09/28/2006 | US20060217297 Dimerized peptide |
| 09/28/2006 | US20060217296 For treatment and/or prevention of loss of body weight and body fat, cachexia, stimulation of appetite, food intake, stimulation of weight gain, and/or increasing body fat mass |
| 09/28/2006 | US20060217295 Neuroprotective macrocyclic compounds and methods for their use |
| 09/28/2006 | US20060217294 Compounds binding to p-selectin |
| 09/28/2006 | US20060217293 Coupling low-molecular substances to a modified polysaccharide |
| 09/28/2006 | US20060217292 Vitronectin receptor antagonist compounds and their use in the preparation of diopharmaceuticals |
| 09/28/2006 | US20060217291 Radiosensitizer |
| 09/28/2006 | US20060217290 Insulin analogs having protracted time action |
| 09/28/2006 | US20060217289 Administering a polypeptide having an oxime-containing non-natural amino acid, from a translation system of: a polynucleotide comprising a selector codon encoding the polypeptide, a tRNA comprising the oxime-containing amino acid |
| 09/28/2006 | US20060216824 Paramyxovirus vector encoding ribozyme and utilization thereof |
| 09/28/2006 | US20060216788 CASH (CASPASE HOMOLOGUE) with death effector domain, modulators of the function of FAS |
| 09/28/2006 | US20060216786 Feline interferon-alpha proteins |
| 09/28/2006 | US20060216758 Antibodies to transferrin receptor-like proteins |
| 09/28/2006 | US20060216746 Novel protein and DNA thereof |
| 09/28/2006 | US20060216745 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 09/28/2006 | US20060216739 Insulin-like growth factor binding protein |
| 09/28/2006 | US20060216732 drug screening; identifying a therapeutic for decreasing intraocular pressure raised due to frizzled related protein (FRP) overexpression; contacting a trabecular meshwork cell expressing a Wnt pathway component or a frizzled related protein gene product with a test compound |
| 09/28/2006 | US20060216727 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/28/2006 | US20060216710 Screening for compound that activates or inhibits activity of Aster Associated Protein; over-expression disrupts mitotic spindle assembly and leads to aberrant and abortive mitosis |
| 09/28/2006 | US20060216691 contacting MHC/HLA molecule with a pool of HCV-peptides whereby a HCV-peptide which has a binding capacity to MHC/HLA molecule binds to such MHC/HLA molecule and form a complex, detecting the complexe, assaying the complex in a T cell assay for T cell activation capacity, assaying T cell epitopes |
| 09/28/2006 | US20060216356 Detection of antibacterial activity in excretory secretory product of adult trichuris suis |
| 09/28/2006 | US20060216354 Vector for oral administration |
| 09/28/2006 | US20060216351 Pharmaceutical Compositions of Dispersions of Drugs and Neutral Polymers |
| 09/28/2006 | US20060216339 Neuronal pain pathway |
| 09/28/2006 | US20060216330 Peptides having an ace inhibiting effect |
| 09/28/2006 | US20060216310 administering to mammal more than one dose of a composition comprising live Newcastle Disease Virus in an amount sufficient to cause tumor regression |
| 09/28/2006 | US20060216309 Identification of genes |
| 09/28/2006 | US20060216308 Genomic sequence that encode ptorprotein; drug for prevention, therapy of infections; induce immunology response |
| 09/28/2006 | US20060216304 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 09/28/2006 | US20060216303 Processes and products with modified antibodies of human milk fat globule specificity |
| 09/28/2006 | US20060216301 Kdr peptides and vaccines containing the same |
| 09/28/2006 | US20060216297 Method and composition for reducing blood sugar levels or fat storage by targeting cathepsin |
| 09/28/2006 | US20060216296 Compositions and methods for promoting or inhibiting angiogenesis |
| 09/28/2006 | US20060216295 Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy |
| 09/28/2006 | US20060216294 Method of modulation |
| 09/28/2006 | US20060216292 Treatment of neurodegenerative diseases |
| 09/28/2006 | US20060216291 Glycoprotein VI and uses thereof |
| 09/28/2006 | US20060216290 Diagnostics and therapeutics for diseases associated with g-protein coupled protease activated receptor 1 (Par1) |
| 09/28/2006 | US20060216287 EPH-like receptor protein tyrosine kinases |
| 09/28/2006 | US20060216283 Inhibition of secretion from non-neuronal cells |
| 09/28/2006 | US20060216281 Process for producing aglycon and flavor-improved food containing the aglycon by diglycosidase, and converting agent to be used in the process |
| 09/28/2006 | US20060216280 Fibrinogen-based tissue adhesive containing an elastase inhibitor |
| 09/28/2006 | US20060216279 Myostatin inhibiting fusion polypeptides and therapeutic methods thereof |
| 09/28/2006 | US20060216270 DNA 19355 polypeptide, a tumor necrosis factor homolog |
| 09/28/2006 | US20060216269 Dendritic cell tumor injection (DCTI) therapy |
| 09/28/2006 | US20060216262 Method of treating skin using composition including chaperonin proteins |
| 09/28/2006 | US20060216258 Water-in-silicone emulsion compositions |
| 09/28/2006 | US20060216251 Topical formulations and methods of use |
| 09/28/2006 | US20060216242 Suspending vehicles and pharmaceutical suspensions for drug dosage forms |
| 09/28/2006 | DE19917195B4 Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor Peptide to induce an immune response against tumor cells containing this pharmzeutische compositions, uses thereof, nucleic acid coding therefor and these nucleic acid expression vector containing |
| 09/28/2006 | DE19903876B4 Verfahren zur in-vitro-Bildung und Anreicherung von Interleukin-1 Rezeptor-Antagonisten A method for in vitro generation and accumulation of interleukin-1 receptor antagonist |
| 09/28/2006 | DE19724791B4 Thrombin hemmende Peptide, deren Verwendung und diese enthaltende pharmazeutische Zusammensetzungen Thrombin-inhibiting peptides, their use and pharmaceutical compositions containing them |
| 09/28/2006 | DE102005063179A1 Cosmetic or dermatological composition for topical skin treatment, used e.g. to increase epidermal thickness, contains a Vitamin B6 component and a compound that stimulates collagen synthesis |
| 09/28/2006 | CA2814267A1 Sclerostin and the inhibition of wnt signaling and bone formation |
| 09/28/2006 | CA2611859A1 Cellulases, nucleic acids encoding them and methods for making and using them |
| 09/28/2006 | CA2602956A1 Therapy of prostate cancer with ctla4 antibodies and hormonal therapy |
| 09/28/2006 | CA2602914A1 Statherin peptide and use in medicine |
| 09/28/2006 | CA2602893A1 Use of adnf polypeptides for treating peripheral neurotoxicity |
| 09/28/2006 | CA2602545A1 Phenyl-n-acyl derivatives of amines and amino acids, a process for the preparation thereof, a pharmaceutical composition and the use thereof |
| 09/28/2006 | CA2602520A1 Use of the mst protein for the treatment of a thromboembolic disorder |
| 09/28/2006 | CA2602479A1 Mechanisms of osteoinduction by lim mineralization protein-1 (lmp-1) |
| 09/28/2006 | CA2602182A1 Influenza therapeutic |